<- Go home

Added to YB: 2015-12-10

Pitch date: 2015-12-10

ADPT:US [bullish]

Adaptive Biotechnologies Corporation

-45.68%

current return

Author Info

No bio for this author

Company Info

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases.

Market Cap

$2.8B

Pitch Price

$39.01

Price Target

N/A

Dividend

N/A

EV/EBITDA

-182.80

P/E

-53.14

EV/Sales

9.26

Sector

Life Sciences Tools and Services

Category

N/A

Show full summary:
ADEPTUS HEALTH INC ADPT:US

A summary for this pitch has not been created yet.

Read full article (0 min)